Suppr超能文献

缺血诱导的肾移植过程中 DNA 超甲基化预测慢性移植物损伤。

Ischemia-Induced DNA Hypermethylation during Kidney Transplant Predicts Chronic Allograft Injury.

机构信息

Departments of Nephrology.

Laboratories of Experimental Transplantation.

出版信息

J Am Soc Nephrol. 2018 May;29(5):1566-1576. doi: 10.1681/ASN.2017091027. Epub 2018 Apr 2.

Abstract

Ischemia during kidney transplant causes chronic allograft injury and adversely affects outcome, but the underlying mechanisms are incompletely understood. In tumors, oxygen shortage reduces the DNA demethylating activity of the ten-11 translocation (TET) enzymes, yielding hypermethylated genomes that promote tumor progression. We investigated whether ischemia similarly induces DNA hypermethylation in kidney transplants and contributes to chronic injury. We profiled genome-wide DNA methylation in three cohorts of brain-dead donor kidney allograft biopsy specimens: a longitudinal cohort with paired biopsy specimens obtained at allograft procurement (preischemia; =13), after implantation and reperfusion (postischemia; =13), and at 3 or 12 months after transplant (=5 each); a cross-sectional cohort with preimplantation biopsy specimens (=82); and a cross-sectional cohort with postreperfusion biopsy specimens (=46). Analysis of the paired preischemia and postischemia specimens revealed that methylation increased drastically in all allografts on ischemia. Hypermethylation was caused by loss of 5-hydroxymethylcytosine, the product of TET activity, and it was stable 1 year after transplant. In the preimplantation cohort, CpG hypermethylation directly correlated with ischemia time and for some CpGs, increased 2.6% per additional hour of ischemia. Hypermethylation preferentially affected and reduced the expression of genes involved in suppressing kidney injury and fibrosis. Moreover, CpG hypermethylation in preimplantation specimens predicted chronic injury, particularly fibrosis and glomerulosclerosis, 1 year after transplant. This finding was validated in the independent postreperfusion cohort, in which hypermethylation also predicted reduced allograft function 1 year after transplant, outperforming established clinical variables. We highlight a novel epigenetic basis for ischemia-induced chronic allograft injury with biomarker potential.

摘要

肾移植过程中的缺血会导致慢性移植物损伤,并对结果产生不利影响,但其中的潜在机制尚未完全阐明。在肿瘤中,缺氧会降低 ten-11 易位(TET)酶的 DNA 去甲基化活性,导致超甲基化的基因组,从而促进肿瘤的进展。我们研究了缺血是否会以类似的方式诱导肾移植中的 DNA 超甲基化,并导致慢性损伤。我们对三批脑死亡供体肾移植活检样本进行了全基因组 DNA 甲基化分析:一个纵向队列,包含在移植器官获取时(缺血前;=13)、植入和再灌注后(缺血后;=13)以及移植后 3 或 12 个月(每个时间点各=5)获得的配对活检样本;一个横断面队列,包含移植前活检样本(=82);以及一个横断面队列,包含再灌注后活检样本(=46)。对缺血前和缺血后的配对样本进行分析发现,所有移植物在缺血后都发生了剧烈的甲基化增加。这种高甲基化是由 TET 活性产物 5-羟甲基胞嘧啶的丢失引起的,并且在移植后 1 年仍然稳定。在移植前队列中,CpG 高甲基化与缺血时间直接相关,对于一些 CpG,每增加 1 小时缺血,甲基化增加 2.6%。高甲基化优先影响并降低了参与抑制肾损伤和纤维化的基因的表达。此外,移植前标本中的 CpG 高甲基化预测了 1 年后的慢性损伤,特别是纤维化和肾小球硬化。这一发现在独立的再灌注后队列中得到了验证,其中高甲基化也预测了 1 年后移植物功能的降低,优于现有的临床变量。我们强调了缺血诱导的慢性移植物损伤的新的表观遗传基础,并具有生物标志物的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c51/5967765/b1ef6fda0617/ASN.2017091027absf1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验